MindBio debuts AI speech tool to spot substance abuse

MindBio Therapeutics (CSE:MBIO) develops the world's first AI prediction tool for drug and alcohol intoxication using voice analysis.
The Market Online Video

Developing a neurosciences platform with potential applications across several indications

In this Capital Compass episode, Marvel Biosciences outlines progress on MB-204, its neuroscience platform targeting autism, Rett syndrome, Fragile X, and Alzheimer’s disease ahead…

MediPharm Labs announces CEO transition as David Pidduck steps down

MediPharm Labs (TSX:LABS) CEO David Pidduck will step down on January 23, 2026, and will remain on the Board to support the transition.

An immunotherapy value play advancing the fight against bladder cancer

An in-depth look at BioVaxys Technology (CSE:BIOV), a micro-cap stock combining a promising drug pipeline with irrational investor pessimism.

Theralase and Ferring ink deal for new bladder cancer study

Theralase (TSXV:TLT) and Ferring Pharmaceuticals will evaluate a new combination therapy for high-risk non-muscle invasive bladder cancer.

Buzz on the Bullboards: Energy shockwaves, market movers, and cross-border shifts

From geopolitical shocks in Venezuela to bold plays in fusion and cannabis, this week’s stories share a common thread ....

DiagnosTear: A diagnostic technology stock at the forefront of ocular disease

Diagnostear Technologies (CSE:DTR) is playing a leading-edge role in the diagnosis of ocular diseases through its tear-based TeaRx platform.

The 5-Minute Investor Podcast, Ep. 40: Retail stocks for Christmas 2025

Listen to episode 40 of Stockhouse's 5-Minute Investor Podcast, featuring analysis on retail stocks Roots and Kits Eyecare.

RENK better than Hensoldt? Risk at Novo Nordisk! Billion-dollar opportunity with RZOLV Technologies!?

RZOLV Technologies nears a breakthrough with its non-toxic gold leaching solution. Updates on RENK’s rebound and Novo Nordisk’s outlook.

Buzz on the Bullboards: Cannabis stock split, major financing, and battery breakthrough

Inflation concerns, lofty valuations, and growing uncertainty around returns from have prompted investors to reassess their AI exposure.

Kits Eyecare posts record Black Friday and Cyber Monday sales

Kits Eyecare (TSX:KITS) notched record sales over Black Friday and Cyber Monday, building conviction in its track record of profitable growth.

UniDoc deploys Health Cubes at Verizon Innovation Labs

UniDoc Health Corp. (CSE:UDOC) installed two Health Cubes at Verizon Innovation Labs in Los Angeles and San Francisco, with a third planned.

Canopy Growth expands Australian medical cannabis product suite

Canopy Growth adds new softgel capsules into the Australian market under its Spectrum Therapeutics medical cannabis brand.